Long-term infusion of levodopa/carbidopa is effective in patients with advanced Parkinson's disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1324, 2002-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levodopa/carbidopa and Parkinson's disease progression

By  

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

The Association between Adherence to Levodopa/Carbidopa/Entacapone Therapy and Healthcare Utilization and Costs among Patients with Parkinson's Disease: A Retrospective Claims-Based Analysis

By Delea Thomas E.  

CNS Drugs, Vol. 25, Iss. 1, 2011-01 ,pp. : 53-66

Adis International

Access to resources Recommend Favorite

Levodopa/carbidopa: Subacute axonal neuropathy in elderly patients: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1356, 2011-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite

Oral and Infusion Levodopa-Based Strategies for Managing Motor Complications in Patients with Parkinson's Disease

By Antonini Angelo  

CNS Drugs, Vol. 24, Iss. 2, 2010-02 ,pp. : 119-129

Adis International

Access to resources Recommend Favorite

Levodopa/carbidopa: Malnutritional neuropathy after intestinal gel infusion: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1420, 2012-01 ,pp. : 33-33

Adis International

Access to resources Recommend Favorite